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Hematopoietic stem cells (HSCs) function to 
maintain blood homeostasis throughout life   
via their unique ability to differentiate into all 
blood cell types and to self-renew. These prop-
erties, along with the robust ability of HSCs to 
engraft myeloablated recipients in the setting   
of BM transplantation, have established the 
clinical paradigm for therapeutic stem cell use 
(Weissman, 2000).
Originally described by Till and McCulloch 
(1961), HSCs were first experimentally defined 
by their ability to form macroscopic colonies in 
the spleens (CFU-S) of irradiated recipients after 
BM transplantation that histological examina-
tion revealed contained multiple blood lineages, 
and  cytological  examination  revealed  were 
clonally derived (Becker et al., 1963). Together 
with the demonstration that a subset of CFU-S 
colonies had the potential to reform colonies 
when transplanted into secondary recipients 
(Siminovitch et al., 1963), the defining proper-
ties of hematopoietic stem cells—multipotency 
and self-renewal—were established. In the 50 yr 
since these seminal studies were conducted, the 
experimental  study  of  HSCs  has  flourished, 
leading to a profound level of understanding of 
their biology. These efforts were enabled through 
the development of several in vivo and in vitro 
assays that permitted evaluation of HSC self-
renewal and multilineage potential, and by meth-
ods that allowed purification of HSCs by FACS. 
HSCs were initially reported to be enriched 
within  the  Thy1lowLineage  fraction  of  the 
murine BM (Muller-Sieburg et al., 1986), and 
subsequently cells with a  Thy1lowLineageSca1+ 
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Hematopoietic stem cells (HSCs) are the best-characterized tissue-specific stem cells, yet 
experimental study of HSCs remains challenging, as they are exceedingly rare and methods 
to purify them are cumbersome. Moreover, genetic tools for specifically investigating HSC 
biology are lacking. To address this we sought to identify genes uniquely expressed in HSCs 
within the hematopoietic system and to develop a reporter strain that specifically labels 
them. Using microarray profiling we identified several genes with HSC-restricted expres-
sion. Generation of mice with targeted reporter knock-in/knock-out alleles of one such 
gene, Fgd5, revealed that though Fgd5 was required for embryonic development, it was not 
required for definitive hematopoiesis or HSC function. Fgd5 reporter expression near exclu-
sively labeled cells that expressed markers consistent with HSCs. Bone marrow cells isolated 
based solely on Fgd5 reporter signal showed potent HSC activity that was comparable to 
stringently purified HSCs. The labeled fraction of the Fgd5 reporter mice contained all HSC 
activity, and HSC-specific labeling was retained after transplantation. Derivation of next 
generation mice bearing an Fgd5-CreERT2 allele allowed tamoxifen-inducible deletion of a 
conditional allele specifically in HSCs. In summary, reporter expression from the Fgd5 locus 
permits identification and purification of HSCs based on single-color fluorescence.
© 2014 Gazit et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after   
the publication date (see http://www.rupress.org/terms). After six months it is   
available  under  a  Creative  Commons  License  (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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BM cells isolated based solely on reporter signal of the Fgd5 
reporter mice showed robust HSC activity, with all stem cell 
activity residing within the labeled fraction. These results 
demonstrate that HSCs can be identified and purified from 
the BM of Fgd5 reporter mice by single color fluorescence. 
Finally, the development of Fgd5-CreERT2 mice permitting 
inducible deletion of Floxed alleles specifically in HSCs rep-
resents an invaluable genetic resource for exploring gene 
function in HSC biology.
RESULTS
Systems-wide microarray screen identifies genes with HSC-
restricted expression in the adult hematopoietic system
To identify genes specifically expressed in HSCs within the 
hematopoietic system, we compiled the expression profiles   
of 37 different hematopoietic cell types comprising the vast 
majority of hematopoietic progenitor and effector cells   
(Fig. 1 A). These datasets include published microarray data 
from our group and others that were carefully curated from 
publicly available databases. As many of these datasets were 
generated in different laboratories, we subjected them to a 
number of quality control (QC) measures in accordance with 
current standards using the ArrayQualityMetrics package of 
R/Bioconductor.  In  total,  122  expression  profiles  passed   
QC and were normalized together in a single database. Using 
this database, we were readily able to identify genes that 
showed highly restricted expression in diverse hematopoi-
etic cell types (Fig. 1 B). Analysis of such cell type–specific 
gene lists indicated that previously established and validated 
cell type–specific genes could be identified (Fig. 1 B). These 
included genes known to mediate critical functions in spe-
cific cell types, as well as genes whose products are routinely 
used to phenotypically define different cell types with no known 
function in the specific cell type (Fig. 1 B). For example, 
Ncr1, which is critical in NK cells (Gazit et al., 2006), Bcl11b, 
which is involved in specifying T cell identity (Wakabayashi 
et al., 2003), and the adult -globin in erythroblasts (Pászty 
et al., 1995) were highly restricted to these cells in our data-
base (Fig. 1 B). Similar results were obtained for other he-
matopoietic cell types and, in all cases the cell type–specific 
genes were associated with a very high degree of statisti-
cal confidence due to the fact that only FACS-purified cells 
were used in the generation of the data, and also due to the 
large number of samples and biological replicates analyzed 
(Tables S1 and S2).
We next sought to identify genes predominantly expressed 
in HSCs (immunopurified as LSKFlk2CD34low/) in com-
parison to their downstream progenitor and effector progeny. 
This analysis identified 323 probe sets corresponding to 235 
unique annotated genes with highly restricted expression in 
HSCs (Fig. 1 C, Fig. S1, and Table S2). This list overlapped 
significantly with the results of previous studies in which   
expression profiling of different hematopoietic cell types has 
been used to define HSC transcriptional signatures and ex-
plore their biology (Chambers et al., 2007a; Gazit et al., 2013; 
Fig. 1 D). Interestingly, many of the genes we identified were 
immunophenotype were shown to possess long-term multi-
lineage repopulating activity (Spangrude et al., 1988). The 
immunophenotype of HSCs was further refined, culminating 
with the demonstration that single cells purified from the 
LineageSca1+c-kit+ (LSK)CD34/low fraction of the BM of 
adult mice could function to long-term multilineage recon-
stitute irradiated recipients at the clonal level (Osawa et al., 
1996). Additional cell surface markers that have also been 
used to enrich for HSC activity include: CD105 (Chen et al., 
2002), Flk2/Flt3 (Christensen and Weissman, 2001), CD201/
PROCR (Balazs et al., 2006), ESAM (Ooi et al., 2009; Yokota   
et al., 2009), and CD150, CD48, and CD244 (Kiel et al., 2005a) 
among others. In addition to immunophenotype, intravital dye 
efflux activity has also proven to be an effective strategy for en-
riching for HSC activity (Bertoncello et al., 1985; Wolf et al., 
1993; Goodell et al., 1996).
Although immunophenotype combined with flow cyto-
metry has become the principle technique used for identi-
fying and studying diverse cells types, genetically engineered 
reporter strains have also enabled the identification and study 
of other cell types, including tissue-specific stem cells from 
other organs. For example, rapidly cycling intestinal stem cells 
were identified with the use of an Lgr5 reporter (Barker et al., 
2007), whereas a population of more slowly cycling stem cells 
in the intestinal crypt were marked with a reporter for telom-
erase (Montgomery et al., 2011). In the developing embryo, 
reporter strains for Isl1 (Laugwitz et al., 2005) and WT1 
(Zhou et al., 2008) have been combined with lineage-tracing 
experiments to identify cardiac progenitors in the developing 
heart. In the skin, a Tet-inducible H2B-GFP reporter stain 
was used in conjunction with a keratinocyte-specific driver 
to isolate label-retaining stem cells in the epidermis (Tumbar 
et al., 2004). A similar H2B-GFP label retention strategy was 
later used by two independent groups to explore the turnover 
of HSCs, showing that a label-retaining population of cells 
with potent HSCs activity resides in a state of prolonged dor-
mancy during steady-state homeostasis (Wilson et al., 2008; 
Foudi et al., 2009). Importantly, depending on vector design, 
introducing  reporter  cassettes  into  specific  genomic  loci 
(knock-in) can also lead to the disruption of the targeted 
gene, permitting analysis of the null (knockout) genotype when 
targeted alleles are crossed to homozygosity.
With the goals of identifying novel genes that could be 
used to specifically report on HSC activity within the murine 
BM, we performed a system-wide microarray screen of he-
matopoietic stem, progenitor, and effector cells, and identified 
a set of genes whose expression was highly restricted to the 
HSC compartment. Generation of mice with targeted re-
porter knock-in/knock-out alleles at three of the identified 
genes, Sult1a1, Clec1a, and Fgd5 revealed that whereas knock-
out of Sult1a1 and Clec1a were viable and had normal HSC 
function, nullizygosity of Fgd5 was embryonic lethal at mid-
gestation, though the generation and function of definitive 
HSCs was not affected by loss of Fgd5. Of the three reporter 
alleles, only Fgd5 explicitly marked immunophenotypic HSCs 
in the adult marrow at steady state and after transplantation. JEM Vol. 211, No. 7 
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Figure 1.  Identification of HSC-specific genes. (A) Schematic representation of the hematopoietic hierarchy showing cell types with expression 
profiles used in this study framed in red. (B) Heat map showing relative expression (from red, high, to blue, low) of genes identified as cell type specific in 
the indicated cell types, with asterisks (*) marking genes with well-established roles in the given cell type. (C) Heat map showing relative expression of 
representative genes identified as HSC-specific (for complete list see Fig. S1). (D) Venn diagram of HSC-enriched gene sets published in Gazit et al. (2013) 
(2013), Chambers et al. (2007a), and this study. Genes expressed >2.3-fold higher in HSCs relative to downstream populations examined in each study 
were selected from the current study and also the Chambers et al. (2007a) dataset. Percentage overlap of our HSC-enriched gene set with others is  
presented on the bottom.1318 Fgd5 reporter expression specifically marks HSCs | Gazit et al.
adult Clec1aGFP/+ mice showed almost negligible expression 
in HSCs, whereas HSCs identified from the BM of Sult1a1GFP/+ 
mice  were  completely  negative  for  reporter  fluorescence   
(Fig. 2 A). In contrast, immunophenotypic HSCs from the 
Fgd5mCherry/+ mice were almost uniformly positive for reporter 
signal (mCherry; Fig. 2 A). Although there could be several 
explanations for the absence of signal in HSCs of Clec1aGFP/+ 
and Sult1a1GFP/+ mice, we focused on the Fgd5mCherry/+ mice 
for further characterization.
Whereas Fgd5mCherry/+ mice clearly showed labeling of im-
munophenotypic HSCs, we sought to further determine the 
spectrum of BM cells expressing mCherry. To address this, we 
gated BM cells from the Fgd5mCherry/+ mice into mCherry+ 
and mCherry fractions, and then determined the immuno-
phenotype of these cells by co-staining with a panel of mark-
ers. This analysis revealed that in contrast to mCherry cells, 
a significant fraction of the mCherry+ cells were negative for 
the lineage markers associated with mature blood cells (B220, 
Mac1, GR-1, Ter119, CD3, CD4, and CD8); positive for c-Kit 
and Sca1; negative for CD48; and positive for CD150 (Fig. 2 B). 
By gating sequentially through these markers, the vast major-
ity of the mCherry+ cells of Fgd5mCherry/+ BM co-stained with 
markers of immunophenotypic HSCs (LSKCD48CD150+; 
Fig. 2 B, bottom).
Our expression profiling data showed that whereas Fgd5 
expression in the murine BM was almost exclusively restricted 
to HSCs, low-level expression was also detected in multipotent 
progenitor cells. To examine this, we stained the BM of   
Fgd5mCherry/+ mice with several different marker combinations 
that are commonly used to identify HSCs and discriminate 
them from multipotent progenitor cell subsets within the primi-
tive LSK fraction of the murine BM. Using markers associated 
with the “Slam code” (Kiel et al., 2005b), the vast majority 
of HSCs (LSKCD150+CD48) were fluorescently labeled 
(Fig. 2 C). In contrast, the most proximal multipotent progeni-
tors (LSKCD150CD48) showed low-level expression of 
the reporter, whereas the more distal LSKCD150CD48+ pro-
genitors were predominantly negative. Similarly, when CD34 
and Flk2 were used to immunophenotypically define HSCs and 
multipotent progenitors (Osawa et al., 1996; Christensen and 
Weissman, 2001; Rossi et al., 2005), HSCs (LSKFlk2CD34) 
were largely positive, whereas the MPP1/ST-HSC (LSKFlk2 
CD34+) population expressed lower levels of signal, and   
the MPP2 subset (LSKFlk2+CD34+) showed very little signal 
(Fig. 2 D), consistent with our microarray data (Fig. 1). Similar 
results were found using other marker immunophenotypic 
strategies to identify HSCs and multipotent progenitors in-
cluding PROCR/CD201 (Balazs et al., 2006; Fig. 2 E) and 
ESAM (Ooi et al., 2009; Yokota et al., 2009; Fig. 2 F). Collec-
tively, these results indicate that immunophenotypic HSCs are 
almost exclusively labeled in the BM of Fgd5mCherry/+ mice.
Fgd5 deficiency does not impair HSC function  
and is not required for definitive hematopoiesis
Because the targeting of the Fgd5 locus places a mCherry   
cassette into the first exon of the Fgd5 coding region and is 
also expressed at low levels in multipotent progenitors (MPP1s), 
which represent the most proximal progenitor to HSCs and 
have previously been referred to in the literature as short-
term HSCs (ST-HSCs; Fig. 1 C). Among the HSC-enriched 
genes were several that encode proteins with well-established 
functional roles in HSC biology, such as Cdkn1c (Matsumoto 
et al., 2011; Zou et al., 2011), Meis1 (Pineault et al., 2002), and 
Ndn (Kubota et al., 2009), in addition to many genes that have 
not yet been reported to have a functional role in HSC biol-
ogy. We chose to focus on three genes of this latter group, 
Clec1a, Fgd5, and Sult1a1, which showed highly restricted ex-
pression in our database (Fig. 1 C). In addition to expression 
specificity, these genes were selected, in part, based on consid-
eration of their genomic structure (intron/exon, repetitive   
elements), which suggested that they would be amenable to 
targeting by homologous recombination. Of these, Clec1a en-
codes a C-type lectin type II transmembrane receptor that has 
been shown to be expressed in human and rat dendritic and 
endothelial cells (Colonna et al., 2000; Sobanov et al., 2001; 
Thebault et al., 2009), and has been reported to play an im-
munomodulatory role in allograft tolerance in rats (Thebault 
et al., 2009). Sult1a1 encodes a cytosolic transferase studied in 
human cells for its ability to conjugate sulfate to various phe-
nolic substrates (Wilborn et al., 1993; Raftogianis et al., 1997; 
Hildebrandt et al., 2009). Fgd5 encodes a protein predicted to 
have GTP-exchange (guanine nucleotide exchange factor 
[GEF]) activity that has been studied exclusively in the con-
text of endothelial cell biology (Cheng et al., 2012; Kurogane 
et al., 2012). To our knowledge, Fgd5, Clec1a, and Sult1a1 
have not previously been studied in the context of HSC biol-
ogy. Collectively, these results demonstrate that expression of 
Fgd5, Clec1a, and Sult1a1 is predominantly confined to HSCs 
in the adult hematopoietic system.
Immunophenotypic HSCs are labeled  
by mCherry in Fgd5mCherry/+ mice
To generate reporter mice and begin to explore the possible 
roles for Clec1a, Sult1a1, and Fgd5 in HSC biology, constructs 
were made to target each locus by homologous recombina-
tion in embryonic stem (ES) cells using a knock-in/knock-
out strategy. In all cases, constructs were designed to place 
a fluorescence reporter cassette (either mCherry into Fgd5, 
or eGFP•CreERT2 into Clec1a and Sult1a1) in-frame with 
the protein coding sequence that would be expected to be 
expressed under endogenous regulatory control. At the same 
time, correct targeting of the loci is expected to generate null 
alleles for each of the genes. Sequence verified targeting con-
structs were introduced into ES cells derived from C57BL/6 
mice,  correctly  targeted  ES  cell  clones  were  identified  by 
Southern blotting, and germline transmission of the targeted 
alleles was established (not depicted).
To characterize the utility of the targeted alleles to label 
HSCs, we isolated BM cells from young adult Fgd5mCherry/+, 
Sult1a1GFP/+ and Clec1aGFP/+ mice and control littermates and 
immunostained for HSCs using a panel of well-defined mark-
ers (LSKCD48CD150+). Disappointingly, the BM of young JEM Vol. 211, No. 7 
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Figure 2.  Reporter-labeled cells in BM of  
Fgd5mCherry/+ mice are synonymous with immuno-
phenotypic HSCs. (A) Histograms (colored) of re-
porter expression within immunophenotypic HSCs 
(LSKCD48CD150+) from the BM of mice targeted at 
Clec1aeGFP, Sult1a1eGFP, and Fgd5mCherry in comparison to 
the wild-type background (gray). (B) BM mCherry+ (red 
histograms) and mCherry (black histograms) cells of 
Fgd5mCherry/+ mice co-stained and gated individually (top) 
or sequentially (bottom) through lineage (Ter119, Mac-1, 
Gr-1, B220, CD3, CD4, and CD8), c-Kit, Sca1, CD48, and 
CD150. (C–F) Sub-fractionation of primitive LSK cells 
from Fgd5mCherry/+ (red histograms) or Fgd5+/+ (gray histo-
grams) mice into immunophenotypic HSCs (right, green 
gates) and multipotent progenitors (blue and black gates) 
by (C) CD150 and CD48, (D) CD34 and flk2, (E) PROCR 
and CD34, and (F) ESAM and CD34. Percentage mCherry+ ± 
SD is shown and a minimum of n = 3 mice for each stain 
were analyzed.
predicted to generate a null allele, we wanted to determine if 
inactivation of one or both Fgd5 alleles would affect HSC 
function. To address this in the setting of Fgd5 heterozygosity, 
we competitively transplanted 106 BM cells from Fgd5mCherry/+ 
or wild-type (Fgd5+/+) control littermates (CD45.2) against   
1 × 106 wild-type BM cells (CD45.1) into lethally irradiated 1320 Fgd5 reporter expression specifically marks HSCs | Gazit et al.
wild-type HSCs, serial transplantation into secondary (2°) re-
cipients was performed. Peripheral blood analysis up to   
20 wk after transplant revealed that HSCs derived from both 
Fgd5mCherry/+ and Fgd5+/+ mice robustly reconstituted 2° hosts 
showing comparable repopulating activity, and no differences 
in lineage output (Fig. 3 B). Thus, inactivation of one Fgd5 
allele has no adverse consequence on the long-term repopu-
lating or self-renewal potential of HSCs.
congenic recipients (CD45.1). Transplant recipients were 
bled at monthly intervals and reconstitution of CD45.2 test 
cells and their contribution to myeloid lineage granulocytes, 
macrophages/monocytes, lymphoid lineage B cells, and T cells, 
was determined (Fig. 3 A). This showed that Fgd5 heterozy-
gosity had no adverse effect on HSC function in respect to 
total repopulation or lineage potential in primary (1°) trans-
plant recipients. To further challenge the Fgd5mCherry/+ and 
Figure 3.  Fgd5 is required for embry-
onic development but is dispensable for 
definitive HSC formation and function. 
(A) Primary (1°) and (B) secondary (2°) trans-
plantation of whole BM cells from Fgd5mCherry/+ 
(red) and Fgd5+/+ (black) mice showing total 
donor reconstitution (left) over the time 
course of transplantation and lineage break-
down of donor cells at 16 (1°) and 20 (2°) wk 
after transplant (right). Number of recipi-
ents: n = 9 and 5 (Fgd5mCherry/+) and 8 and 4 
(Fgd5+/+) for 1° and 2° transplants, respec-
tively, error bars indicate SD. (C) Table  
summarizing genotypes Fgd5+/+ (WT),  
Fgd5mCherry/+ (Het), and Fgd5mCherry/mCherry (null) 
and number of embryos recovered at indi-
cated time points of embryonic development 
from Fgd5+/mCherry X Fgd5+/mCherry crosses.  
* indicates the presence of one or more  
morphologically abnormal embryos.  
(D) Dissecting microscope images of E12.0 
embryos derived from Fgd5mCherry/+ X  
Fgd5mCherry/+ timed matings showing geno-
type and gross morphology of the embryos.  
(E) Histological sections showing the 
mCherry signal at the aorta gonad meso-
nephros (AGM) region of E11.5 embryos 
derived from Fgd5mCherry/+ X Fgd5+/+ timed 
matings stained with FITC-Isolectin (for  
endothelial cells) and counterstained with 
DAPI. Figure shows separate channels and 
overlay of a representative Fgd5+/+ (top)  
and Fgd5mCherry/+ (bottom) embryos (bars,  
100 µm). (F) Schematic of experimental strat-
egy for AGM-explants and transplantation.  
(G) Primary (1°) and (H) secondary (2°) trans-
plantation of AGM explants derived from 
Fgd5+/+ (black), Fgd5mCherry/+ (red), and  
FgdmCherry/mCherry (blue) embryos showing total 
donor reconstitution (top) over the time 
course of transplantation and lineage break-
down of donor cells in individual recipient at 
16 wk after transplant (bottom). Granulo-
cytes (GN), macrophage/monocytes (M),  
B cells, and T cells are indicated by color. 
Data are shown for all embryos transplanted 
in primary and secondary recipients.JEM Vol. 211, No. 7 
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assays, indicating that neither gene was required for HSC 
long-term repopulating activity (unpublished data).
Fgd5mCherry identifies BM cells with potent  
hematopoietic stem cell activity
Having  determined  that  the  mCherry+  BM  fraction  of   
Fgd5mCherry/+ mice labels cells that express markers consistent 
with immunophenotypic HSCs (Fig. 2), and also that the tar-
geted allele had no adverse effect on HSC function (Fig. 3), 
we next sought to test the functional activity of the labeled 
cells directly. We sorted defined numbers of cells based solely 
on mCherry positivity from the BM of Fgd5mCherry/+ mice 
(CD45.2), and competitively transplanted them into lethally 
irradiated congenic recipients (CD45.1). We also sorted im-
munophenotypic HSCs (LSKCD150+CD48, hereafter re-
ferred to as HSCSlam) and competitively transplanted these in 
parallel. In a series of independent experiments, mCherry+ 
cells, and HSCSlam were transplanted at 200, 120, 40, 20, or 5 
cells per recipient, and peripheral blood reconstitution was 
monitored for 16 wk (Fig. 4, A–E). At all transplant doses, the 
mCherry+ cells and HSCSlam gave rise to long-term donor 
chimerism that was statistically comparable (Fig. 4 F). In each 
of the 200, 120, 40, and 20 cell transplants, all recipient mice 
transplanted with either mCherry+ cells or HSCSlam showed 
donor-derived multilineage reconstitution 16 wk after trans-
plant, whereas at the 5-cell dose, 11/13, and 8/13 recipi-
ents were multilineage reconstituted when mCherry+ cells 
or HSCSlam were transplanted, respectively (Fig. 4, A–E). These 
results demonstrate that the mCherry+ fraction of Fgd5mCherry/+ 
BM is highly enriched with potent repopulating activity that is 
functionally comparable, on a per cell basis, to HSCs sorted 
by rigorous immunophenotypic markers.
In addition to the ability to give rise to long-term multi-
lineage reconstitution in 1° transplant recipients, HSCs are 
most rigorously experimentally defined by their ability to sus-
tain activity during serial transplantation. To address this, we 
again isolated mCherry+ cells or HSCSlam from Fgd5mCherry/+ 
or  Fgd5+/+  mice  (CD45.2),  respectively,  and  competitively 
transplanted  250  cells  of  each  into  irradiated  congenic 
(CD45.1) recipients. Analysis of 1° recipients revealed, as   
before, that the mCherry+ cells and HSCSlam performed com-
parably (Fig. 5 A). 21 wk after transplant, 2 × 106 BM cells 
derived from the 1° recipients were transplanted into 2° hosts 
(CD45.1). Throughout  the  28-wk-long  experiment,  all   
2° hosts showed donor-derived multilineage reconstitution 
(Fig. 5 B). 31 wk after transplant, BM cells were harvested 
from the 2° hosts and 5 × 106 cells were transplanted into ter-
tiary (3°) recipients (CD45.1). As we had observed in the 2° 
hosts, both the mCherry+ donor cells and HSCSlam controls 
continued to show potent long-term multilineage repopulat-
ing activity in all of the 3° recipients (Fig. 5, C and D). These 
experiments demonstrate that the mCherry+ fraction of   
Fgd5mCherry/+ BM contains potent multilineage repopulating 
potential, and extensive self-renewal potential in vivo.
We next analyzed the BM reconstitution of recipients that 
had been transplanted with either mCherry+ cells or HSCSlam. 
We next sought to determine if Fgd5 nullizygosity would 
have an impact on HSC function. To address this, we set   
Fgd5mCherry/+ X Fgd5mCherry/+ crosses but were unable to obtain 
any viable Fgd5mCherry/mCherry offspring, indicating that ablation of 
Fgd5 is lethal for embryos. We examined the requirement for 
Fdg5 during embryonic development and found that whereas 
no Fgd5mCherry/mCherry embryos could be identified at embry-
onic day 13.5 (E13.5) or later, null embryos could be ob-
tained at Mendelian numbers at E11.5 (Fig. 3 C). Gross 
examination and genotyping of embryos from timed matings 
showed  that  although  many  Fgd5-null  embryos  appeared 
morphologically normal at E11.5, the presence of resorbed 
embryos and Fgd5mCherry/mCherry embryos with clear morpho-
logical abnormalities at E12.0 indicate that most Fgd5-null 
embryos die around E11.5–E12.0 (Fig. 3, C and D). Histo-
logical examination of the aorta-gonad mesonephros (AGM) 
region  of  E11.5  control  and  morphologically  normal   
Fgd5mCherry/+ embryos revealed that all endothelial cells, includ-
ing the aorta, were mCherry+ (Fig. 3 E), which is consistent 
with the previously reported pan-endothelial cell expression 
of Fgd5 in developing embryos (Cheng et al., 2012). Because 
the timing of death (E11.5–E12.0) is shortly after the devel-
opmental time point at which definitive HSCs first emerge in 
the embryo at the AGM region (Dzierzak and Speck, 2008), 
the possibility that definitive hematopoiesis may be defec-
tive or impaired in absence of FGD5 was raised. To test this 
possibility directly, we dissected the AGM region of E11.5 
embryos derived from Fgd5mCherry/+ X Fgd5mCherry/+ crosses and 
cultured  them  for  4  d  at  an  air/liquid  interface  using  an 
adapted  protocol  (Medvinsky  and  Dzierzak,  1996; Taoudi   
et al., 2008), and then competitively transplanted all the cells 
from the AGM explants into irradiated recipients (Fig. 3 F). 
These experiments showed that although there was some 
variability in lineage output, as might be expected with this 
protocol, AGM explants arising from Fgd5+/+, Fgd5mCherry/+,   
or Fgd5mCherry/mCherry embryos all gave rise to HSCs capable   
of long-term multilineage reconstitution in 1° recipients   
(Fig. 3 G). To further test the functional capacity of the Fgd5- 
deficient HSCs, 2 × 106 BM cells from the 1° hosts were seri-
ally transplanted into 2° recipients. These experiments showed 
that AGM-derived HSCs of all Fgd5 genotypes were able to 
give rise to long-term, multilineage reconstitution in 2° hosts 
(Fig. 3 H).
Collectively, these results indicate that Fgd5 is required for 
embryonic development, but is not required for the genera-
tion of definitive HSCs, and further that loss of one or both 
Fgd5 alleles does not impair the long-term self-renewal or 
multilineage differentiation potential of HSCs in serial trans-
plantation assays.
It is also important to note that although the targeting of 
Clec1a or Sult1a1 did not faithfully label HSCs, we were 
nonetheless able to determine that neither gene was required 
for embryonic development as homozygous null mice were 
born at Mendelian numbers and appeared phenotypically 
normal. Moreover, BM from mice harboring Clec1a or 
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give rise to immunophenotypic HSCs in vivo and, further, 
that the near exclusive labeling of HSCs observed in the BM 
of Fgd5mCherry/+ mice is faithfully maintained even after the 
extensive challenge of primary transplantation.
All HSC activity resides within the  
mCherry+ fraction of Fgd5mCherry/+ BM
We next sought to determine if all HSC activity was con-
fined to the mCherry+ fraction of the Fgd5mCherry/+ BM. To 
address this, we sorted the BM of Fgd5mCherry/+ mice into 
Similar to the chimerism observed in the peripheral blood 
(Fig. 4), the BM was robustly reconstituted with CD45.2 
donor-derived cells regardless of whether mCherry+ cells or 
HSCSlam had been transplanted (Fig. 6). Co-staining the BM 
with a panel of markers showed, as we had observed in the 
steady state (Fig. 2), that the mCherry+ signal was restricted to 
the immunophenotypic HSC (LSKflk2CD34) compart-
ment, with only a minor fraction of the LSK multipotent 
progenitors expressing lower levels of labeling (Fig. 6 C). These 
results show that the mCherry+ cells are able to self-renew to 
Figure 4.  Fgd5mCherry identifies cells with 
potent HSC activity. (A–E) Transplantation 
of 200 (A), 120 (B), 40 (C), 20 (D), or 5 (E) 
mCherry+ cells from Fgd5mCherry/+ mice (red) or 
control LSKCD48CD150+-sorted HSCs  
(HSCSlam) from wild-type mice (black) showing 
total donor reconstitution (left) over the time 
course of transplantation, and lineage break-
down of donor cells in individual recipient 
mice at 16-wk after transplant (right). Aster-
isks (*) in E indicate mice that were not multi-
lineage reconstituted at the 5-cell transplant 
dose. Granulocytes (GN), macrophage/mono-
cytes (M), B cells, and T cells are indicated by 
color. (F) Mean total donor chimerism of each 
of the experiments shown in A–E. Error bars 
indicate SD, P > 0.05, by Student’s t test.JEM Vol. 211, No. 7 
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the 100,000-mCherry cell transplants yielded only short-
term reconstitution that gradually diminished to very low 
levels at later time-points (Fig. 7, B and C). Peripheral blood 
analysis of the few remaining mCherry donor-derived cells 
at 16-wk (experiment #1) or 24-wk (experiment #2) after 
transplant revealed that virtually all were B and T cells, which 
mCherry+ and mCherry fractions, and competitively trans-
planted either 100 or 100,000 cells, respectively, into irradi-
ated recipients in two independent experiments (Fig. 7, A–C). 
As we had previously observed (Figs. 4–5), the 100-mCherry+ 
cell transplants all yielded robust long-term, multilineage re-
constitution in both experiments (Fig. 7, B–D). In contrast, 
Figure 5.  Fgd5mCherry-labeled HSCs have 
extensive self-renewal and repopulating 
potential. (A) Primary (1°) transplantation of 
250 mCherry+ cells from Fgd5mCherry/+ mice 
(red), or 250 control LSKCD48CD150+-sorted 
HSCs (HSCSlam) from wild-type mice (black) 
showing total donor reconstitution over the 
time course of transplantation (n = 4 recipi-
ents per group). (B) Secondary (2°; n = 3  
recipients per group) and (C) tertiary (3°) 
transplantation (number of recipients n = 6 
[Fgd5mCherry/+] and 5 [HSCSlam]) of whole BM 
cells from the 1° recipients described in A 
showing total donor reconstitution over the 
time course of transplantation. (D) Lineage 
breakdown of donor cells at individual recipi-
ents at 20 wk after transplant from the 3° 
transplants. Granulocytes (GN), macrophage/
monocytes (M), B cells, and T cells are indi-
cated by color.
Figure 6.  Labeling of HSCs by  
Fgd5mCherry/+ is retained after transplanta-
tion. (A and B) BM analysis of recipient mice 
transplanted with 120 LSKCD48CD150+ 
HSCs (HSCSlam) from wild-type mice (A) or 120 
mCherry+ cells from Fgd5mCherry mice (B), ana-
lyzed 8 mo after transplant showing donor-
derived (CD45.2) chimerism and contribution 
to BM compartments revealed by co-staining 
with antibodies against lineage, c-Kit, Sca1, 
flk2, and CD34. (C) Histograms showing 
mCherry signal in the indicated cell fractions 
from the BM of recipient mice transplanted 
with 120 HSCSlam cells from wild-type mice 
(left ) or 120 mCherry+ cells from Fgd5mCherry 
mice 8 mo after transplant. Representative 
data from n = 4 mice per group.1324 Fgd5 reporter expression specifically marks HSCs | Gazit et al.
the fact that only 1 out of 10 independent recipients trans-
planted with 100,000 mCherry cells showed minor granu-
locyte reconstitution 16 wk after transplant, indicates that most, 
if not all, of HSC activity resides in the mCherry+ fraction of 
the Fgd5mCherry/+ mice.
Pan-endothelial Fgd5 expression in adult BM,  
and inducible HSC-specific Cre-mediated deletion  
revealed by next generation Fgd5 mice
Our functional data to this point indicates that Fgd5 would be 
an ideal locus for the construction of additional genetic tools 
designed to study the functional, molecular, and therapeutic 
can be long-lived (Fig. 7 D). Importantly, although the mCherry+ 
cell transplants all gave rise to sustained, high levels of granu-
locyte  chimerism  indicating  robust,  ongoing  HSC  activity 
(Bhattacharya et al., 2006; Bryder et al., 2006), granulocyte re-
constitution was progressively extinguished in the recipients 
transplanted with the mCherry fraction indicating an ab-
sence of HSC activity (Fig. 7, E and F). The sole exception to 
this was one of the recipients of 100,000 mCherry cells in 
experiment #1 showed very low donor-derived granulocyte 
reconstitution 16 wk after transplant (Fig. 7 E). Although we 
cannot formally exclude the possibility that HSC activity re-
sides in the mCherry fraction of the BM at very low frequency, 
Figure 7.  All HSCs are labeled by Fgd5mCherry.  
(A) Gating strategy used for sorting reporter-positive 
and -negative fractions set using Fgd5+/+ (top) and  
Fgd5mCherry/+ (bottom) mice. (B and C) Transplantation of 
100 mCherry+ (red) or 100,000 mCherry (gray) cells 
from Fgd5mCherry/+ mice showing total donor reconstitu-
tion over the time course of transplantation in experi-
ment 1 (B) and experiment 2 (C). (D) Peripheral blood 
analysis of representative recipients from experiment 2 
showing donor reconstitution (CD45.2) and contribu-
tion to granulocytes (Mac1+Gr1+), macrophages/mono-
cytes (Mac1+Gr1), B cells (Mac1, B220+CD3) and  
T cells (Mac1+, B220-CD3+) analyzed 24-wk after trans-
plant. (E and F) Peripheral blood analysis showing gran-
ulocyte chimerism plotted against the time course of 
transplantation in experiments 1 (E) and 2 (F). n = 5 per 
group in experiment 1; n = 4 (Fgd5mCherry/+); n = 5 
(Fgd5+/+) in experiment 2.JEM Vol. 211, No. 7 
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to ZsGreen+ LSKCD150+ HSCs (Fig. 9 A), with essentially 
no dTomato expression detected in other hematopoietic 
compartments (Fig. 9 B).
DISCUSSION
In this study, we set out to identify genes with restricted ex-
pression in the HSC compartment of the murine BM, and 
then target the endogenous loci of several identified genes in 
mouse  ES  cells  to  generate  reporter  knock-in/knock-out   
alleles. Mice bearing such alleles could potentially be used to 
identify HSCs by single-color fluorescence without the need 
for immunostaining, which could have great utility for ad-
dressing outstanding questions related to HSC biology. At the 
same time, our knock-in/knock-out approach would allow 
us to examine the requirement of the targeted genes for HSC 
development and function. To achieve these goals, we used a 
microarray approach in which we compared the expression 
profiles of highly purified HSCs to that of 36 downstream 
progenitor and effector cell types. Previous studies using re-
lated approaches have been successful in identifying genes that 
function in HSCs or in downstream populations (Ivanova   
et al., 2002; Park et al., 2002; Forsberg et al., 2005; Kiel et al., 
2005a; Shojaei et al., 2005; Balazs et al., 2006; Luckey et al., 2006; 
Chambers et al., 2007a,b; Seita et al., 2012; Gazit et al., 2013), as 
well  as  genes  whose  products  serve  as  antigens  that  have   
been used to facilitate identification of HSCs such as Esam 
(Forsberg et al., 2005), the Slam code (CD150, CD48, and 
CD244; Kiel et al., 2005a), and Procr/CD201 (Balazs et al., 
2006). Mindful of the fact that HSCs share several func-
tional attributes with their proximal multipotent progenitor 
progeny, and also, to a lesser degree, with downstream oligo-
potent and lineage-restricted progenitors, we included such 
populations  in  our  microarray  screen  reasoning  that  this 
would allow us to more precisely identify genes with HSC-
restricted expression. With this said, it must be recognized that 
identifying a gene as “specific” to any cell type is ultimately 
limited by the spectrum and comprehensiveness of the sam-
ples studied. Bearing this potential caveat in mind, using the 
hematopoietic database assembled for this study, we were able 
to identify 235 annotated genes with highly restricted expres-
sion in HSCs, many of which have not been previously stud-
ied in the context of HSC biology.
To assess the potential functional role that such novel 
identified genes might play in HSCs, and to increase the like-
lihood of identifying a genomic locus that upon targeting 
would lead to faithful HSC labeling, we focused on three 
genes with highly HSC-restricted expression. The knock-in/
knock-out targeting strategy we used allowed us to deter-
mine that neither Clec1a nor Sult1a1 are required for normal 
mammalian development, and both appeared to be dispens-
able for HSC function in transplantation experiments (un-
published data). In contrast, whereas Fgd5 heterozygotes 
developed normally and showed no deficit in HSC function, 
Fgd5 nullizygosity was embryonic lethal at mid-gestation, in-
dicating a critical, nonredundant function for FGD5 during 
development. Recent studies have shown that Fgd5 expression 
properties of HSCs. To expand the repertoire of HSC-specific 
genetic resources we generated two additional strains by tar-
geting the Fgd5 locus in ES cells. With the intent of generat-
ing a brighter Fgd5 reporter that could be detected using 
488-nm lasers common to most flow cytometers and FACS 
machines, we knocked-in tandem ZsGreen cassettes sepa-
rated by a 2A peptide into the Fgd5 locus. Similar to the   
Fgd5mCherry/+ mice (Fig. 2), the vast majority of ZsGreen+ cells 
were  lineage  (lin)  and  CD48,  and  c-Kit+,  Sca1+,  and 
CD150+ (Fig. 8 A). Consistent with the brighter expression 
of the Fgd5ZsGr•ZsGr/+ reporter, and also with the expression of 
Fgd5 transcript observed in multipotent progenitor subsets 
(Fig. 1 C), LSKCD48CD150 (MFI 6,031) and to a lesser 
extent, LSKCD48+CD150 (MFI 1,566) progenitor subsets, 
expressed Fgd5-ZsGreen signal, albeit at lower levels than ob-
served in LSKCD48CD150+ HSCs (MFI 11,343; unpub-
lished data). Fgd5 reporter signal was detected in all HSC 
subtypes  fractionated  by  differential  CD150  expression  in 
young (4 mo) and mid-aged (14 mo) mice (Fig. 8, B and C; 
Beerman  et  al.,  2010;  Morita  et  al.,  2010).  Interestingly, 
CD150hi HSCs, which are believed to be the most primitive 
HSC  subset  (Beerman  et  al.,  2010;  Morita  et  al.,  2010), 
showed the highest mean fluorescence intensity of Fgd5 re-
porter signal, followed by CD150lo HSCs and CD150neg 
HSCs (Fig. 8 C), suggesting that the intensity of Fgd5 reporter 
expression tracks with HSC potency, and further that the 
Fgd5 reporter faithfully tracks the changes in the HSC popu-
lation during aging.
Using this strain we next sought to examine Fgd5 expression 
in the adult BM using laser-scanning cytometry (Nombela- 
Arrieta et al., 2013). Consistent with previous studies suggest-
ing pan-endothelial expression of Fgd5 (Cheng et al., 2012; 
Kurogane et al., 2012), all blood vessels in the adult BM ex-
pressed high levels of the Fgd5 reporter (Fig. 8 D and Video 1).
The most widely used genetic resources for investigating 
gene function in HSCs via loss-of-function approaches are 
the Mx1-Cre (Kühn et al., 1995) and Vav1-Cre (de Boer   
et al., 2003) strains. Although both strains are robust, they both 
have  limitations  for  specifically  studying  gene  function  in 
HSCs as both are pan-hematopoietic. Moreover, Vav1-Cre is 
noninducible, thus precluding temporal control of gene dele-
tion, and although Mx1-Cre is inducible, its induction by the 
synthetic  double-stranded  RNA  polyinosinic-polycytidylic 
acid (polyI:polyC) elicits a systemic interferon response that is 
known to activate and drive HSCs into cycle (Baldridge et al., 
2010; Essers et al., 2009) potentially confounding interpreta-
tions using this strain, particularly in regard to HSC cell cycle 
status and regulation of quiescence. To circumvent these is-
sues, we targeted an inducible CreERT2 cassette along with a 
ZsGreen reporter cassette into the Fgd5 locus in ES cells to 
derive Fgd5ZsGr•CreERT2/+ mice. These mice were then crossed 
to mice bearing a floxed-stop dTomato reporter allele at the 
Rosa26 locus. After tamoxifen induction, we examined the 
specificity and efficacy of Cre-mediated deletion. These   
experiments showed that dTomato expression after Cre- 
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Figure 8.  Fgd5ZsGreen•ZsGreen/+ reporter expression marks all HSC subtypes and also endothelial cells in the BM. (A) BM ZsGreen+ (green histo-
grams) and ZsGreen (gray histograms) cells of Fgd5ZsGreen•ZsGreen/+ mice co-stained and gated through lineage (Ter119, Mac-1, Gr-1, B220, CD3, CD4, 
CD8, and IL7R), c-Kit, Sca1, CD48, and CD150 (n = 5 or more). (B) Sub-fractionation of LKSFlk2CD34/low into CD150hi (red gates), CD150lo (green 
gates), and CD150neg (blue gates) HSC subtypes from young (4 mo) and mid-aged (14 mo) Fgd5+/+ and Fgd5ZsGreen•ZsGreen/+ mice. (C) Histograms show-
ing ZsGreen expression of each of the indicated HSC subtypes from the mice shown in B. MFI of each of the indicated HSC subtypes is shown (bot-
tom). A minimum of n = 3 mice for each stained were analyzed with the exception of 14-mo-old mouse (n = 1). (D) Adult femoral BM cavity 
microvascular network based on 3D reconstruction of a series of confocal images showing arterial and sinusoidal microvessels (stained with Laminin 
in red) and Fgd5Zsgreen•ZsGreen/+ reporter expression (green). Projection depth 54 µm. Grid squares (white box) are 51.3 µm × 51.3 µm (left) and 42.9 µm ×  
42.9 µm (right).JEM Vol. 211, No. 7 
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identifies HSCs. Mice bearing a reporter for the Gata2 tran-
scription factor that is not specifically expressed in HSCs   
(Fig. S1) were found to be useful for enriching for HSC ac-
tivity when sorted in combination with immunostaining for 
Sca1 (Suzuki et al., 2006). Similarly, although mice bearing a 
reporter  allele  at  the  Abcg2  locus  predominantly  labeled 
Ter119+ erythroid cells in the murine BM as expected from 
expression analysis (Fig. S1), HSCs could be identified when 
used in combination with side-population activity, and anti-
body staining to exclude lineage+ cells (Tadjali et al., 2006). 
Interestingly, although Bmi-1 is broadly expressed through-
out hematopoiesis (Fig. S1), mice bearing a GFP knock-in 
allele at the Bmi-1 locus, which is critical for HSC function 
(Park et al., 2003), were used to demonstrate that BM cells 
expressing the highest levels of GFP contained HSC activity 
when sorted in combination with additional HSC markers 
(Hosen et al., 2007). In an elegant study, Goyama et al. (2008) 
targeted the Evi-1 locus, which is required for HSC function, 
by cleverly knocking-in an Evi-1 cDNA-IRES-GFP rescue/
reporter cassette, which largely rescued HSC activity (Kataoka 
et al., 2011). This study showed that although the majority of 
outside of the hematopoietic system is predominantly re-
stricted to endothelial cells in developing and adult mice and 
in zebrafish embryos (Cheng et al., 2012). Fgd5 is also ex-
pressed in several human endothelial cell lines, where it has 
been suggested to play a role regulating CDC42 activity dur-
ing  capillary  formation  (Kurogane  et  al.,  2012). The  im-
portance of Fgd5 in endothelial cell biology was recently 
demonstrated in a study in which murine Fgd5 was knocked-
down by siRNA, and overexpressed, showing that FGD5 reg-
ulates vascular pruning during endothelial cell remodeling 
(Cheng et al., 2012). These studies raise the possibility that the 
embryonic lethality associated with loss of FGD5 may result 
from defective vasculogenesis. Consistent with this we ob-
served robust endothelial expression of FGD5 in the developing 
embryo and also in adult BM. With regards to hematopoiesis, 
we showed that despite the midgestation lethality, Fgd5- 
nullizygosity did not impair the formation or function of defin-
itive HSCs (Fig. 3), which retained self-renewal and multilineage 
differentiation potential comparable to wild-type controls.
Several previous studies have targeted a variety of loci 
with  the  intent  of  establishing  a  reporter  that  specifically 
Figure 9.  Tamoxifen induced Cre activity 
in Fgd5ZsGreen•CreERT2/+ mice exclusively tar-
gets CD150+ HSCs. (A) Flow plots of tamoxi-
fen-treated Fgd5ZsGreen•CreERT2/+:Rosa26+/+ and 
Fgd5ZsGreen•CreERT2/+:Rosa26LoxSTOPLoxdTomato/+ mice 
showing primitive LSK compartment subfrac-
tionated into CD150- and CD150+ population 
(left), with each population then gated 
through ZsGreen and dTomato (right). (B) Cre-
mediated dTomato expression in control 
Fgd5ZsGreen•CreERT2/+; Rosa26+/+ and experimen-
tal Fgd5ZsGreen•CreERT2/+; Rosa26loxSTOPloxdTomato/+ 
mice upon tamoxifen induction shown in the 
indicated BM populations including Lineage, 
Lineage+, LincKit+Sca1 (myeloid progeni-
tors), LSKCD150 cells, LSK, and LSKCD150+ 
HSC (n = 3 per group).1328 Fgd5 reporter expression specifically marks HSCs | Gazit et al.
derived from C57BL/6 mice were electroporated with linearized constructs 
and clones were positively selected with G418 and negatively selected by the 
diphtheria toxin cassette of the constructs. Clones were manually picked, 
expanded, and screened by Southern blot. Positive clones were expanded, 
validated, and injected into blastocysts, and germline transmission was con-
firmed. All strains used were on a C57BL/6 background including CD45.1 
and  CD45.2  congenic,  and  the  Rosa26-LoxP-STOP-LoxP-tdTomato 
(stock# 007914) was obtained from The Jackson Laboratory. All experi-
ments involving mice were done per institutional guidelines of The Harvard 
Medical School Standing Committee on Animals, with IACUC approval.
FACS analysis and cell sorting. BM mononuclear cells prepared over His-
topaque 1083 (Sigma-Aldrich) were stained for 1.5 h in PBS 2 mM EDTA, 
2% FBS at 4°C with combinations of the following antibodies: the lineage 
markers Ter119, Mac-1 (m1/70), Gr-1 (8C5), CD3 (17A2), CD4 (RM4-5), 
CD8 (53–6.7), B220 (RA3-6B2), and IL7Ra (A7R34); CD34 (RAM34), Flk2 
(A2F10), c-kit (2B8), Sca1 (D7), CD150 (TC15-12F12.2), CD48 (HM48-1), 
CD201 (eBio1560), and ESAM (1G8; all from BioLegend or eBioscience). 
After staining, cells were washed and suspended with DAPI (1 µg/ml), and 
kept on ice. FACSAria II (BD) or MoFlo Astrios (Beckman Coulter) equipped 
with 590-nm lasers for optimal detection of the mCherry signal were used for 
cell sorting and analysis. Transplanted cells were double sorted for purity.
Transplantations and peripheral blood analysis. Congenic recipient 
mice were lethally irradiated (900 rad), and donor cells, mixed with 2 × 105 
whole BM competitor cells in 200 µl PBS 2 mM EDTA, and 2% FBS, were 
injected into the tail vein. At the indicated time points, 2–3 drops of blood 
were collected from the tail and added to 150 µl Alsever’s solution (Sigma-
Aldrich). Blood samples were treated with 10 ml ACK solution (0.15 M 
NH4Cl, 1 mM KHCO3, and 0.1 mM EDTA) for 5 min at room temperature 
and washed two times with PBS. Leukocytes were stained with PerCP/
Cy5.5-Ter119 (Ter119), PE/Cy7-Mac1 (m1/70), Fitc-Gr1 (8C5), PE-CD3 
(17A2), APC/Cy7-B220 (RA3-6B2), A647-CD45.1 (A20), and PacBlue-
CD45.2 (104); all from BioLegend. Cells were washed and suspended with 
propidium iodide (1 µg/ml) and analyzed on FACSCanto II (BD). Analysis 
was done using FlowJo software (Tree Star). For serial-transplants (secondary 
and tertiary), 2 × 106 cells whole BM cells were transferred into lethally irra-
diated congenic recipients.
AGM explants, culturing, and imaging. The procedure we used was 
based on a previously published protocol (Medvinsky and Dzierzak, 1996; 
Taoudi et al., 2008). In brief, the aorta-gonad-mesonephros (AGM) of E11.5 
embryos (CD45.2) were individually dissected (excluding somites) and cul-
tured at the air-liquid interface on Durapore 0.65-µm filters (Millipore) sus-
pended on IMDM media containing 20% serum and 100 ng/ml SCF, IL-3, 
and Flt3L (PeproTech). After 4 d, cells were dissociated with Collagenase I 
(Worthington), filtered, and mixed with whole BM competitor cells (CD45.1) 
and transplanted into lethally irradiated congenic recipients (CD45.1). 
For  microscopic  visualization  of  the AGM  region,  E11.5  embryos  from   
Fgd5mCherry/+ x Fgd5mCherry/+ timed matings were fixed in 2% PFA for 30 min, 
equilibrated in 30% sucrose, embedded in OCT, and cryosectioned, followed 
by staining with FITC-conjugated Isolectin and DAPI. Images were taken 
using a Ti-E microscope (Nikon).
3D immunohistology of BM.  Thick femoral bone slices from Fgd5ZsGreen•ZsGreen/+ 
mice were generated as previously described (Nombela-Arrieta et al., 2013). 
BM slices were blocked overnight in 0.2% PBS, 1% Triton, and 10% BSA and 
stained with rabbit anti-laminin (Sigma-Aldrich) for 2 d in blocking solution, 
washed overnight in PBS, and stained for 2 d with DyLight549 donkey anti–
rabbit IgG (Jackson ImmunoResearch Laboratories). Whole-mount stained 
slices were washed in PBS and incubated overnight in FocusClear (Cel-
Explorer Laboratory). For observation under the confocal microscope, BM 
slices were mounted in glass slides embedded in FocusClear. Confocal mi-
croscopy was performed with a LSM700 system (Carl Zeiss). Image stacks 
were rendered into 3D volumes using Volocity Software (Improvision) and 
exported to Photoshop (Adobe Inc.) for processing.
cells of the primitive LSK compartment were GFP-labeled in 
these mice, only the GFP+ fraction when sorted in combina-
tion with additional HSC markers including LinSca1+c-kit+ 
exhibited HSC activity (Kataoka et al., 2011). Thus, to the 
best of our knowledge, although several reporter mice have 
been developed that label hematopoietic stem and progenitor 
cells, the goal of establishing a reporter strain that faithfully 
and more specifically labels HSCs based on single-color fluor-
escence has not been previously achieved.
Although Clec1a and Sult1a1 were identified as being 
among the most HSC-restricted genes from our expression 
screen, targeting expression reporter cassettes into the coding 
region of these genes did not lead to expression in the HSC 
compartment. Several reasons could underlie this disappoint-
ing outcome, including the possibility that targeting the loci 
in the manner that we did sufficiently disrupted regulatory 
elements necessary for expression in HSCs. In contrast to Clec1a 
and Sult1a1, targeting of the Fgd5 locus yielded a reporter 
that almost exclusively labels HSCs in the murine BM. In   
addition to being essentially synonymous with a myriad of 
markers that are used to immunophenotypically identify 
HSCs (Osawa et al., 1996; Kiel et al., 2005b; Balazs et al., 
2006; Bryder et al., 2006; Ooi et al., 2009), cells sorted solely 
on reporter signal from the Fgd5mCherry/+ mice had potent 
HSC activity that matched the functional potential of rigor-
ously immunopurified HSCs (Kiel et al., 2005b). We demon-
strated that the Fgd5 reporter effectively marked all HSC 
activity in the steady-state BM, which is remarkable in light of 
evidence showing that even widely used protocols that have 
proven very effective in identifying HSCs do not strictly iden-
tify all cells with HSC activity (Morita et al., 2006; Weksberg 
et al., 2008). Moreover, the demonstration that Fgd5 reporter 
activity exclusively identified immunophenotypic HSCs in 
the BM of transplanted mice suggests that even under experi-
mental settings requiring extensive HSC activity and self- 
renewal Fgd5 reporter expression remained a powerful tool 
for identifying HSCs. The Fgd5 reporter and Fgd5-CreERT2 
mice reported here represent invaluable resources for study-
ing the pathways and mechanisms that govern the central 
properties of HSCs under diverse settings.
MATERIALS AND METHODS
Hematopoietic expression database. Microarray data were generated on 
the Affymetrix 430 2.0 platform and included previously unpublished data 
generated in our laboratory in addition to datasets that were curated from 
Gene Expression Omnibus (complete list of accession nos. available in Table 
S1). All datasets were subjected to quality control (QC) measures provided in 
the ArrayQualityMetrics package of R/Bioconductor. Datasets were normal-
ized (gcRMA) using R/Bioconductor. To identify cell type–specific genes we 
applied three filters: (1) only probe sets that had expression values ≥ log 7.0 
were included; (2) Ratio of expression difference for the cell type of interest 
to all others had to be greater than fourfold; (3) Statistical significance for the 
cell type of interest to all others had to be P < 106 by Student’s t test.
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